Literature DB >> 19475608

Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif.

W P Poh1, T Narasaraju, N A Pereira, F Zhong, M C Phoon, P A Macary, S H Wong, J Lu, D R Koh, Vincent T K Chow.   

Abstract

Integrins are critical for initiating T-cell activation events. The integrin-binding motif Arg-Gly-Asp (RGD) was incorporated into the pcDNA 3.1 mammalian expression vector expressing the codon-optimized extracellular domain of SARS coronavirus (SARS-CoV) spike protein, and tested by immunizing C57BL/6 mice. Significant cell-mediated immune responses were characterized by cytotoxic T-lymphocyte (51)Cr release assay and interferon-gamma secretion ELISPOT assay against RMA-S target cells presenting predicted MHC class I H2-Kb epitopes, including those spanning residues 884-891 and 1116-1123 within the S2 subunit of SARS-CoV spike protein. DNA vaccines incorporating the Spike-RGD/His motif or the Spike-His construct generated robust cell-mediated immune responses. Moreover, the Spike-His DNA vaccine construct generated a significant antibody response. Immunization with these DNA vaccine constructs elicited significant cellular and humoral immune responses. Additional T-cell epitopes within the SARS-CoV spike protein that may contribute to cell-mediated immunity in vivo were also identified. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19475608      PMCID: PMC7166745          DOI: 10.1002/jmv.21571

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  42 in total

Review 1.  Immunological capabilities of skeletal muscle cells.

Authors:  K Nagaraju
Journal:  Acta Physiol Scand       Date:  2001-03

2.  Laminin-10 is crucial for hair morphogenesis.

Authors:  Jie Li; Julia Tzu; Yi Chen; Yan-Ping Zhang; Ngon T Nguyen; Jing Gao; Maria Bradley; Douglas R Keene; Anthony E Oro; Jeffrey H Miner; M Peter Marinkovich
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

3.  Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

Authors:  Zhiwei Chen; Linqi Zhang; Chuan Qin; Lei Ba; Christopher E Yi; Fengwen Zhang; Qiang Wei; Tian He; Wenjie Yu; Jian Yu; Hong Gao; Xinming Tu; Agegnehu Gettie; Michael Farzan; Kwok-Yung Yuen; David D Ho
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody.

Authors:  H L Davis; M L Michel; R G Whalen
Journal:  Hum Mol Genet       Date:  1993-11       Impact factor: 6.150

5.  Immune responses to plasmid DNA encoding the hepatitis C virus core protein.

Authors:  L M Lagging; K Meyer; D Hoft; M Houghton; R B Belshe; R Ray
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

6.  CD8+ T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity.

Authors:  R F Castro; S Perlman
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

Review 7.  Characterization of viral proteins encoded by the SARS-coronavirus genome.

Authors:  Yee-Joo Tan; Seng Gee Lim; Wanjin Hong
Journal:  Antiviral Res       Date:  2005-02       Impact factor: 5.970

8.  HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins.

Authors:  Yeou-Ping Tsao; Jian-Yu Lin; Jia-Tsrong Jan; Chih-Hsiang Leng; Chen-Chung Chu; Yuh-Cheng Yang; Show-Li Chen
Journal:  Biochem Biophys Res Commun       Date:  2006-05-26       Impact factor: 3.575

9.  The secret life of ACE2 as a receptor for the SARS virus.

Authors:  Dimiter S Dimitrov
Journal:  Cell       Date:  2003-12-12       Impact factor: 41.582

10.  The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages.

Authors:  Rikke Leth-Larsen; Fei Zhong; Vincent T K Chow; Uffe Holmskov; Jinhua Lu
Journal:  Immunobiology       Date:  2007-01-26       Impact factor: 3.144

View more
  10 in total

1.  Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain.

Authors:  Xingsu Gao; Linlin Fan; Binyang Zheng; Haoze Li; Jiwei Wang; Li Zhang; Jingxin Li; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2022-04-13       Impact factor: 4.526

Review 2.  T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV.

Authors:  William J Liu; Min Zhao; Kefang Liu; Kun Xu; Gary Wong; Wenjie Tan; George F Gao
Journal:  Antiviral Res       Date:  2016-11-11       Impact factor: 5.970

Review 3.  Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design.

Authors:  Xuhua Xia
Journal:  Viruses       Date:  2021-01-14       Impact factor: 5.048

4.  Design and proof-of-concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.

Authors:  Daniela I Staquicini; Fenny H F Tang; Christopher Markosian; Virginia J Yao; Fernanda I Staquicini; Esteban Dodero-Rojas; Vinícius G Contessoto; Deodate Davis; Paul O'Brien; Nazia Habib; Tracey L Smith; Natalie Bruiners; Richard L Sidman; Maria L Gennaro; Edmund C Lattime; Steven K Libutti; Paul C Whitford; Stephen K Burley; José N Onuchic; Wadih Arap; Renata Pasqualini
Journal:  bioRxiv       Date:  2021-03-16

Review 5.  Review on Approved and Inprogress COVID-19 Vaccines.

Authors:  Amir Farnudian-Habibi; Mobina Mirjani; Vahideh Montazer; Shima Aliebrahimi; Iman Katouzian; Saeed Abdolhosseini; Ali Rahmani; Hossein Keyvani; Seyed Nasser Ostad; Mazda Rad-Malekshahi
Journal:  Iran J Pharm Res       Date:  2022-01-24       Impact factor: 1.962

Review 6.  Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges.

Authors:  Idris Nasir Abdullahi; Anthony Uchenna Emeribe; Hafeez Aderinsayo Adekola; Sharafudeen Dahiru Abubakar; Amos Dangana; Halima Ali Shuwa; Sunday Theophilus Nwoba; Jelili Olaide Mustapha; Muyideen Titilope Haruna; Kafayat Adepeju Olowookere; Olawale Sunday Animasaun; Charles Egede Ugwu; Solomon Oloche Onoja; Abdullahi Sani Gadama; Musa Mohammed; Isa Muhammad Daneji; Dele Ohinoyi Amadu; Peter Elisha Ghamba; Nkechi Blessing Onukegbe; Muhammad Sagir Shehu; Chiladi Isomah; Adamu Babayo; Abdurrahman El-Fulaty Ahmad
Journal:  Hum Vaccin Immunother       Date:  2020-09-16       Impact factor: 3.452

7.  Comparative Transcriptomic and Molecular Pathway Analyses of HL-CZ Human Pro-Monocytic Cells Expressing SARS-CoV-2 Spike S1, S2, NP, NSP15 and NSP16 Genes.

Authors:  Anshika Sharma; Joe W Ong; Mun Fai Loke; Eng Guan Chua; Joseph J Lee; Hyung Won Choi; Yee Joo Tan; Sunil K Lal; Vincent T Chow
Journal:  Microorganisms       Date:  2021-05-31

8.  Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2.

Authors:  Zhiqiang Zheng; Vanessa Marthe Monteil; Sebastian Maurer-Stroh; Chow Wenn Yew; Carol Leong; Nur Khairiah Mohd-Ismail; Suganya Cheyyatraivendran Arularasu; Vincent Tak Kwong Chow; Raymond Tzer Pin Lin; Ali Mirazimi; Wanjin Hong; Yee-Joo Tan
Journal:  Euro Surveill       Date:  2020-07

Review 9.  Coronaviruses pandemics: Can neutralizing antibodies help?

Authors:  Phuoc-Bao-Viet Tong; Li-Yun Lin; Tuan Hiep Tran
Journal:  Life Sci       Date:  2020-05-22       Impact factor: 6.780

10.  Immunoinformatic construction of an adenovirus-based modular vaccine platform and its application in the design of a SARS-CoV-2 vaccine.

Authors:  Pedro Soares Porto; Déborah Anjos; Nathânia Dábilla; Simone Gonçalves da Fonseca; Menira Souza
Journal:  Infect Genet Evol       Date:  2020-08-03       Impact factor: 3.342

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.